Location History:
- Jena, DE (1995 - 2009)
- Berlin, DE (2009)
Company Filing History:
7 out of 1,384 
4 out of 192 
3 out of 26 
Years Active: 1995-2009
Title: Gerd Schubert: Innovator in Hormone Replacement Therapy
Introduction
Gerd Schubert is a prominent inventor based in Jena, Germany, known for his significant contributions to the field of hormone replacement therapy. With a total of 16 patents to his name, Schubert has made remarkable advancements in the development of pharmaceutical components that address hormone deficiencies and irregularities.
Latest Patents
Among his latest patents, Schubert has developed mesoprogrestins, which serve as progesterone receptor modulators. These compounds are utilized in hormone replacement therapy (HRT) and are characterized by their unique ability to stabilize the function of the progesterone receptor at an intermediate level of agonistic and antagonistic activity. This innovative approach allows for treatment methods that cannot be achieved with traditional progestins or antiprogestins. Additionally, he has patented compounds with increased antigonadotropic activity specifically designed for female birth control and hormone replacement therapy.
Career Highlights
Throughout his career, Schubert has worked with notable companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG. His work has significantly impacted the pharmaceutical industry, particularly in the development of effective treatments for hormone-related conditions.
Collaborations
Schubert has collaborated with esteemed colleagues, including Sven Ring and Walter Elger, to further advance his research and innovations in hormone therapy.
Conclusion
Gerd Schubert's contributions to hormone replacement therapy through his innovative patents and collaborations have established him as a key figure in the field. His work continues to influence the development of effective treatments for hormone deficiencies and irregularities.